Prev Arrow Stocks

Hims & Hers Health Inc. ($HIMS) Stock Forecast: Up 28.9% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Hims & Hers Health Inc.?

HIMS is a stock of Hims & Hers Health, a company specializing in telehealth and wellness products. The overall market sentiment appears positive for the company.

Why is Hims & Hers Health Inc. going up?

HIMS stock is up 28.9% on Apr 29, 2025 16:35

  • HIMS stock showed strong bullish movement today.
  • The collaboration with Novo Nordisk to offer the weight loss drug Wegovy on its platform seems to have boosted investor confidence in Hims & Hers Health.
  • Expected revenue from the GLP-1 product line, including Wegovy, and the anticipation of robust earnings growth are believed to have influenced the bullish trend in HIMS stock.
  • Investors are hopeful about strategic partnerships and revenue prospects, leading to increased buying interest in HIMS shares.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

Hims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform - Hims & Hers Health ( NYSE:HIMS ) , Novo Nordisk ( NYSE:NVO )

Novo Nordisk's Wegovy now available via Hims & Hers at $599/month, covering all dose strengths with 24/7 care and nutrition support. Hims & Hers' GLP-1 offering, including Wegovy and Zepbound, generated over $225 million in revenue in 2024.

https://www.benzinga.com/25/04/45074872/hims-hers-stock-surges-as-it-collaborates-with-novo-nordisk-to-sell-weight-loss-drug-wegovy-on-its-platform

0 News Article Image Hims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform - Hims & Hers Health  ( NYSE:HIMS ) , Novo Nordisk  ( NYSE:NVO )

Hims & Hers Health, Inc. ( HIMS ) Earnings Expected to Grow: Should You Buy?

Hims & Hers Health (HIMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

https://www.zacks.com/stock/news/2456885/hims-hers-health-inc-hims-earnings-expected-to-grow-should-you-buy

1 Missing News Article Image Hims & Hers Health, Inc.  ( HIMS )  Earnings Expected to Grow: Should You Buy?

Hims & Hers Health Inc. Price History

21.03.2025 - HIMS Stock was down 5.1%

  • Despite HIMS estimating a significant increase in sales and profits, the stock experienced a bearish movement, possibly due to macro challenges affecting its performance.
  • The stock had been performing well in the past few months, gaining 5.8%, but today's bearish movement could be a result of these macro challenges overshadowing its growth prospects.
  • The positive change of +1.04% in the preceding trading day did not hold, indicating a shift in market sentiment possibly triggered by concerns over the company's ability to navigate the current challenges.
  • Investors might be cautious about the company's ability to sustain its growth trajectory amidst the macro challenges, leading to a sell-off and the bearish movement observed today.

28.02.2025 - HIMS Stock was down 7.6%

  • The stock of HIMS experienced a strong bearish movement recently.
  • Smart money investors have taken a notably bearish stance on HIMS options, as a significant percentage have opened trades with bearish sentiments.
  • The stock has been down 7.1% since the last earnings report, prompting concerns about its ability to rebound.
  • The overall options activity for HIMS is leaning towards a bearish outlook, potentially contributing to the downward trend in the stock price.

13.02.2025 - HIMS Stock was down 5.5%

  • Despite HIMS enhancing its offerings and expanding its product line in the health and wellness sector, macro challenges seem to be impacting its performance negatively.
  • An increase in trades by major investors in HIMS might indicate short-term optimism. However, the overall market sentiment has overshadowed this positive sentiment, leading to a strong bearish movement in the stock today.
  • Investors might be cautious due to macro challenges, causing them to sell off their positions in HIMS, contributing to the bearish movement observed today.

16.03.2025 - HIMS Stock was down 5.2%

  • The bearish movement in HIMS stock today could be due to the macro challenges impacting its performance.
  • Despite efforts to enhance offerings and expand products, these challenges seem to have outweighed the positive developments.
  • Investors might be cautious about the company's ability to navigate through these macro challenges successfully, leading to the bearish movement in the stock today.

12.02.2025 - HIMS Stock was down 5.1%

  • Despite bullish sentiment from whales and financial giants in the options market, HIMS stock experienced a bearish trend.
  • Novo Nordisk's decision to lower the costs of Wegovy, a competitor in the health sector, may have impacted investor confidence in HIMS.
  • The discounted price offered by Novo Nordisk could potentially attract customers away from HIMS, leading to a decrease in the stock price.
  • The bearish movement in HIMS stock could be a result of increased competition and pricing pressures in the telehealth and wellness industry.

06.02.2025 - HIMS Stock was down 6.5%

  • Despite surpassing revenue expectations and demonstrating robust subscriber growth, the stock witnessed a downward trend.
  • Market sentiments possibly anticipated higher revenue figures or more substantial subscriber growth, prompting a sell-off.
  • Concerns about the company's future growth trajectory or potential competition within the telehealth sector may have led to pessimism among investors towards the stock.
  • Some investors may have opted to cash out and take profits following a period of solid performance, potentially contributing to the bearish movement.

06.02.2025 - HIMS Stock was down 11.0%

  • Today's downward movement in HIMS stock may be due to profit-taking by investors following a prior period of bullish sentiment.
  • Despite strong Q4 revenue and subscriber growth, the market's reaction could have been influenced by the company meeting, rather than surpassing, EPS expectations.
  • Financial giants' optimistic positions in HIMS options likely initially boosted the stock, but subsequent profit-taking led to a sell-off.
  • Investor focus shifting towards Novo Nordisk's reduced Wegovy costs and stock price rise may have negatively impacted HIMS performance.

26.02.2025 - HIMS Stock was down 5.6%

  • The stock price of HIMS showed a strong bearish movement.
  • Earnings were reported by the company 30 days ago, leading to investor uncertainty about a potential rebound.
  • Options activity revealed a notable number of investors taking a bearish stance, suggesting a lack of confidence in the stock's short-term performance.
  • The recent earnings report and bearish options activity likely played a role in the downward pressure on HIMS stock today.

28.03.2025 - HIMS Stock was down 6.3%

  • The bearish movement in HIMS stock today could be due to investors' disappointment with the company's earnings, despite expectations of growth.
  • It is possible that the actual earnings did not meet the optimistic forecasts, leading to a sell-off of the stock.
  • Investors might have reacted negatively to any potential guidance or outlook provided by the company in the earnings, causing a decline in the stock price.
  • The market sentiment towards HIMS could have shifted due to factors beyond just earnings, such as macroeconomic conditions or industry-specific impacts on the stock.

29.03.2025 - HIMS Stock was up 28.9%

  • HIMS stock showed strong bullish movement today.
  • The collaboration with Novo Nordisk to offer the weight loss drug Wegovy on its platform seems to have boosted investor confidence in Hims & Hers Health.
  • Expected revenue from the GLP-1 product line, including Wegovy, and the anticipation of robust earnings growth are believed to have influenced the bullish trend in HIMS stock.
  • Investors are hopeful about strategic partnerships and revenue prospects, leading to increased buying interest in HIMS shares.

25.02.2025 - HIMS Stock was up 5.7%

  • Despite recent bearish options activity, Hims & Hers Health witnessed a strong bullish movement in the stock market today.
  • The bullish momentum could be linked to positive earnings or key company developments fostering investor confidence.
  • The bearish options activity may not have directly influenced today's stock performance, with market sentiment and other factors likely driving the upward trend.
  • Positive reactions from investors to strategic partnerships, product innovations, or expansion plans might have spurred buying interest, pushing the stock price higher.

02.03.2025 - HIMS Stock was down 7.4%

  • Hims & Hers Health announced an expansion of its personalized weight loss care services, which could have initially sparked investor interest and led to a positive market sentiment.
  • However, the bearish movement could be attributed to the noticeable bearish stance taken by whales in HIMS options trading, indicating a lack of confidence or potential downside risk perceived by large investors.
  • The uncertainty about the market's next move could have also contributed to a sell-off in the stock as investors may have chosen to take profits or cut losses amidst the mixed market sentiment.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.